Preparation of nitrogen heterocycles of spiro[furo[2,3-d]-pyrimidine] pyrimidine derivatives

Synthetic Communications

Volumn 34, Issue 21, 2004, Pages 3915-3923

  Jursic, Branko S ^a   Stevens, Edwin D ^a  

^a UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

Heterocyclic spiro furo pyrimidines; Pyrimidine derivatives; X ray analysis

Indexed keywords

3 [1,1',3,3' TETRAMETHYL 2,2',4,4',6' PENTAOXO 1,1',3,3',4,4',5,6' OCTAHYDRO 2H,2'H SPIRO(FURO[2,3 D]PYRIMIDINE 6,5' PYRIMIDIN) 5 YL]PYRIDINIUM BROMIDE; 3 [1,1',3,3' TETRAMETHYL 2,2',4,4',6' PENTAOXO 1,1',3,3',4,4',5,6' OCTAHYDRO 2H,2'H SPIRO(FURO[2,3 D]PYRIMIDINE 6,5' PYRIMIDIN) 5 YL]QUINOLINIUM BROMIDE; 3 [2,2',4,4',6' PENTAOXO 1,1',3,3',4,4',5,6' OCTAHYDRO 2H,2'H SPIRO(FURO[2,3 D]PYRIMIDINE 6,5' PYRIMIDIN) 5 YL]PYRIDINIUM BROMIDE; 3 [2,2',4,4',6' PENTAOXO 1,1',3,3',4,4',5,6' OCTAHYDRO 2H,2'H SPIRO(FURO[2,3 D]PYRIMIDINE 6,5' PYRIMIDIN) 5 YL]QUINOLINIUM BROMIDE; 4 [1,1',3,3' TETRAMETHYL 2,2',4,4',6' PENTAOXO 1,1',3,3',4,4',5,6' OCTAHYDRO 2H,2'H SPIRO(FURO[2,3 D]PYRIMIDINE 6,5' PYRIMIDIN) 5 YL]PYRIDINIUM BROMIDE; 4 [2,2',4,4',6' PENTAOXO 1,1',3,3',4,4',5,6' OCTAHYDRO 2H,2'H SPIRO(FURO[2,3 D]PYRIMIDINE 6,5' PYRIMIDIN) 5 YL]PYRIDINIUM BROMIDE; 5,6 DIHYDRO 1,3 DIMETHYL 5,6 DI[1',3' DIMETHYL 2',4',6' TRIOXOPYRIMIDIN (5',5') YL]FURO[2,3 D]URACIL; BARBITURIC ACID DERIVATIVE; FURAN DERIVATIVE; HETEROCYCLIC COMPOUND; NITROGEN DERIVATIVE; PYRIMIDINE DERIVATIVE; SPIRO COMPOUND; SPIRO(FURO)PYRIMIDINE DERIVATIVE; SPIRO(FURO[2,3 D]PYRIMIDINE) DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ARTICLE; BROMINATION; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REPRODUCIBILITY; STRUCTURE ANALYSIS; TECHNIQUE; X RAY ANALYSIS;

EID: 7644243787     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-200034786     Document Type: Article

References (15)

1. De Clercq, E. Med. Res. Rev. 2003, 23, 243.
2. (a) Mangiavacchi, S.; Calistri, M.T. Annali di Chimica 1973, 63, 883-6;
3. (b) Wolf, M.; Diebold, J.L. US Patent 3714093;
4. (c) Mamaev, V.P.; Borovik, V.P.; Gorfinkel, M.I.; Ivanovskaya, L.Yu. Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya 1970, 7, 1637.
5. Eiden, F. Pharmazie in Unserer Zeit 1999, 28, 74.
6. (a) Svab, A.; Budesinsky, Z.; Vavrina, J. Coll. Czech. Chem. Comm. 1967, 32, 1582;
7. (b) Ming, Y.; Wamhoff, H. Chem. Ber. 1987, 120, 1433.
8. For instance see: Yasumoto, S.; Yamashita, J.; Hashimoto, S. Japanese Patent JP 54039082.
9. Kato, S.; Poling, M.; van der Helm, D.; Dryhurst, G. J. Am. Chem. Soc. 1974, 96, 5255.
10. Gill, G.B.; Idris, M.S. Tetrahedron 1993, 49, 2119.
11. (a) Jursic, B.S.; Stevens, E.D. Tetrahedron Lett. 2002, 43, 5681;
12. (b) Jursic, B.S.; Stevens, E.D. J. Heterocyclic Chem. 2003, 40, 701.
13. Kosmrlj, J.; Kocevar, M.; Polanc, S. Synth. Comm. 1996, 26, 3583.
14. Neither dibromobarbituric acid (3b) nor open oxidative trimer 4 is isolated in the course of 5 preparations. The NMR spectra of the solid residue after the first step are identical to the NMR spectra of 3b reported previously.[9]
15. Jursic, B.S.; Neumann, D.M. J. Heterocyclic Chem. 2003, 40, 465-474.